This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kim KW, Koh HB, Kim HW, Park JT, Yoo TH, Kang SW. et al. Systolic blood pressure, low-density lipoprotein cholesterol levels, and adverse kidney outcome: results from KNOW-CKD. Hypertens Res. 2023. https://doi.org/10.1038/s41440-023-01230-0.
KDIGO 2021 Clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int Suppl. 2021;99:S1-87. Retrieved from: https://kdigo.org/wp-content/uploads/2016/10/KDIGO-2021-BP-GL.pdf.
Williams B, Mancia. et al. Guía ESC/ESH 2018 sobre el diagnóstico y tratamiento de la hipertensión arterial. Rev Esp Cardiol. 2019;72:160.e1–e78. https://www.revespcardiol.org/es-guia-esc-esh-2018-sobre-el-articulo-S0300893218306791.
Nadkarni GN, Chauhan K, Rao V, Ix JH, Shlipak MG, Parikh CR. et al. Effect of intensive blood pressure lowering on kidney tubule injury: findings from the ACCORD Trial study participants. Am J Kidney Dis. 2019;73:31–38. https://www.sciencedirect.com/science/article/abs/pii/S0272638618308801.
Upadhyay A, Earley A, Haynes SM, Uhlig K. Systematic review: blood pressure target in chronic kidney disease and proteinuria as an effect modifier. Ann Intern Med. 2011;154:541–8. https://www.acpjournals.org/doi/10.7326/0003-4819-154-8-201104190-00335.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Maria-Tablado, M.A. Behavior of albuminuria in patients with a more intense control of their blood pressure. Hypertens Res 46, 1821–1822 (2023). https://doi.org/10.1038/s41440-023-01275-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41440-023-01275-1